In addition, efferocytosis is not just confined to myeloid cells, but MERTK appeared to convey some level of this capability on epithelial, endothelial, astrocytes, and multiple cell types (including tumor cells where apoptotic tumor cells can activate MERTK signaling promoting survival and therapeutic resistance). Here, MERTK is linked to neoplasm.